PTAB Invalidates 2 Anacor Patents In Hedge Fund Challenge
The Patent Trial and Appeal Board on Thursday invalidated two patents for the Anacor Pharmaceuticals Inc. toenail fungus treatment Kerydin, delivering a victory to the Coalition for Affordable Drugs, an organization...To view the full article, register now.
Already a subscriber? Click here to view full article